Literature DB >> 27557376

Prostate cancer mortality according to marginalization status in Mexican states from 1980 to 2013.

Luisa E Torres-Sánchez, Rebeca Espinoza-Giacinto, Rosalba Rojas-Martínez, Consuelo Escamilla-Nuñez, Ruth Argelia Vázquez-Salas, Julio César Campuzano, Eduardo Lazcano-Ponce.   

Abstract

OBJECTIVE: To assess prostate cancer (PC) mortality in Mexico from 1980 to 2013, according to the state marginalization level.
MATERIALS AND METHODS: Using age-adjusted rates in men ≥ 40 years old, we estimated trends and age-cohort-period effects of PC mortality from 1980-2013 according to state marginalization status by using a joinpoint regression model and a Poisson regression model proposed by Holford.
RESULTS: The PC mortality risk has increased nationwide at a constant rate (2% annually) during the past 13 years. The highest annual increase was observed among states with very high (4.4%) and high (7.7%) marginalization rates. In contrast, states with very low levels of marginalization showed a significant reduction of 1.5% per year. The main changes were observed in the 1945-1950 birth year cohorts.
CONCLUSIONS: Differences in PC mortality across regions of Mexico may reflect differences in the timing of the diagnosis and treatment of PC.

Entities:  

Mesh:

Year:  2016        PMID: 27557376     DOI: 10.21149/spm.v58i2.7787

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  2 in total

1.  Incidence, Mortality, and Trends of Prostate Cancer in Mexico from 2000 to 2019: Results from the Global Burden of Disease Study 2019.

Authors:  Saul A Beltran-Ontiveros; Martha A Fernandez-Galindo; Jose M Moreno-Ortiz; Jose A Contreras-Gutierrez; Jesus Madueña-Molina; Eliakym Arambula-Meraz; Emir Leal-Leon; Delia M Becerril-Camacho; Veronica J Picos-Cardenas; Carla Angulo-Rojo; Diana Z Velazquez; Francisco Jimenez-Trejo; Francisco Gallardo-Vera; Daniel Diaz
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575

2.  Prostate Cancer in Latin America: Challenges and Recommendations.

Authors:  Rodolfo Borges Dos Reis; Alejandro Alías-Melgar; Andrés Martínez-Cornelio; Silvia P Neciosup; Juan Pablo Sade; Marcos Santos; Gustavo Martin Villoldo
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.